Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antidepressant
|
| gptkbp:activeIngredient |
gptkb:paroxetine
|
| gptkbp:affiliatedWith |
selective serotonin reuptake inhibitor
|
| gptkbp:alsoKnownAs |
Paroxetine hydrochloride extended-release
|
| gptkbp:contraindication |
concurrent use with MAO inhibitors
|
| gptkbp:eliminationHalfLife |
about 21 hours
|
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
PX-TR
|
| gptkbp:manufacturer |
various generic manufacturers
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
drowsiness dry mouth sexual dysfunction |
| gptkbp:usedFor |
gptkb:generalized_anxiety_disorder
gptkb:panic_disorder gptkb:post-traumatic_stress_disorder gptkb:social_anxiety_disorder gptkb:major_depressive_disorder |
| gptkbp:bfsParent |
gptkb:PX_Index
|
| gptkbp:bfsLayer |
7
|